Julie Earl Molecular Epidemiology and Predictive Tumor Markers Group, Area 3 Ramón y Cajal Health Research Institute (IRYCIS) Biography Publications Institution JoVE Articles Julie Earl has not added a biography. If you are Julie Earl and would like to personalize this page please email our Author Liaison for assistance. Publications Liquid Biopsy and Preclinical Tools for Advancing Diagnosis and Treatment of Patients with Pancreatic Neuroendocrine Neoplasms Critical Reviews in Oncology/hematology. Dec, 2022 | Pubmed ID: 36334880 A Comprehensive Analysis of Candidate Genes in Familial Pancreatic Cancer Families Reveals a High Frequency of Potentially Pathogenic Germline Variants EBioMedicine. Mar, 2020 | Pubmed ID: 32113160 A Label Free Disposable Device for Rapid Isolation of Rare Tumor Cells from Blood by Ultrasounds Micromachines. Mar, 2018 | Pubmed ID: 30424062 Circulating Tumor Cells (Ctc) and Kras Mutant Circulating Free Dna (cfdna) Detection in Peripheral Blood As Biomarkers in Patients Diagnosed with Exocrine Pancreatic Cancer BMC Cancer. Oct, 2015 | Pubmed ID: 26498594 Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue (Video) | JoVE Jesús Frutos Díaz-Alejo*1,2,3,4, Simon April-Monn*5, Marina Cihova6, Verona Buocikova6, Jorge Villalón López1,3, Maria Urbanova6, Carmen G. Lechuga7, Miroslav Tomas6,8, Peter Dubovan6,8, Bárbara Luna Sánchez3, Sonia Camaño Páez3, Alfonso Sanjuanbenito2,9, Eduardo Lobo9, Estefanía Romio de la Heras10, Carmen Guerra2,7, Carolina de la Pinta11, Emma Barreto Melian1,2, Mercedes Rodríguez Garrote1,2, Alfredo Carrato1,2,4, Laura Ruiz-Cañas3,12,13, Bruno Sainz, Jr.2,3,12,13, Ana Torres3, Bozena Smolkova6, Julie Earl1,2,3 1Molecular Epidemiology and Predictive Tumor Markers Group, Area 3, Ramón y Cajal Health Research Institute (IRYCIS), 2The Biomedical Research Network in Cancer (CIBERONC), 3Biobank and Biomodels Platform (PT20/0045), ISCIII research and development platforms in biomedicine and health sciences, BioBank Hospital Ramón y Cajal-IRYCIS, Spanish National Biobanks Network (ISCIII Biobank Register No. B.0000678), Ramón y Cajal Health Research Institute (IRYCIS), 4Faculty of Medicine, University of Alcalá de Henares, 5Institute of Tissue Medicine and Pathology, University of Bern, 6Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, 7Experimental Oncology, Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 8Department of Surgical Oncology, National Cancer Institute, Slovak Medical University, 9Pancreatic and Biliopancreatic Surgery Unit, Hospital Universitario Ramón y Cajal, 10Department of Pathology, Hospital Universitario Ramón y Cajal, 11Department of Radiation Oncology, Hospital Universitario Ramón y Cajal, 12Department of Cancer, Instituto de Investigaciones Biomédicas “Alberto Sols” (IIBM), 13Cancer Stem Cell and Fibroinflammatory Group, Chronic Diseases and Cancer, Area 3, IRYCIS JoVE 65229 Cancer Research 下流循環フリーDNAアプリケーションのための標準化されたリキッドバイオプシー前分析プロトコル Julie Earl1, Silvia Calabuig-Fariñas1, María Eugenia Sarasquete1, Laura Muinelo Romay1, Sara Lopez-Tarruella1, Beatriz Bellosillo Paricio1, Marta Rodríguez1, Karmele Valencia Leoz1, Marta Dueñas Porto1, Noelia Tarazona1, Javier Hernandez Losa1, Rodrigo Almeida Toledo1 1The Liquid Biopsy and Biomarker Working Module, the Biomedical Research Network in Cancer (CIBERONC) JoVE 64123 Cancer Research
Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue (Video) | JoVE Jesús Frutos Díaz-Alejo*1,2,3,4, Simon April-Monn*5, Marina Cihova6, Verona Buocikova6, Jorge Villalón López1,3, Maria Urbanova6, Carmen G. Lechuga7, Miroslav Tomas6,8, Peter Dubovan6,8, Bárbara Luna Sánchez3, Sonia Camaño Páez3, Alfonso Sanjuanbenito2,9, Eduardo Lobo9, Estefanía Romio de la Heras10, Carmen Guerra2,7, Carolina de la Pinta11, Emma Barreto Melian1,2, Mercedes Rodríguez Garrote1,2, Alfredo Carrato1,2,4, Laura Ruiz-Cañas3,12,13, Bruno Sainz, Jr.2,3,12,13, Ana Torres3, Bozena Smolkova6, Julie Earl1,2,3 1Molecular Epidemiology and Predictive Tumor Markers Group, Area 3, Ramón y Cajal Health Research Institute (IRYCIS), 2The Biomedical Research Network in Cancer (CIBERONC), 3Biobank and Biomodels Platform (PT20/0045), ISCIII research and development platforms in biomedicine and health sciences, BioBank Hospital Ramón y Cajal-IRYCIS, Spanish National Biobanks Network (ISCIII Biobank Register No. B.0000678), Ramón y Cajal Health Research Institute (IRYCIS), 4Faculty of Medicine, University of Alcalá de Henares, 5Institute of Tissue Medicine and Pathology, University of Bern, 6Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, 7Experimental Oncology, Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 8Department of Surgical Oncology, National Cancer Institute, Slovak Medical University, 9Pancreatic and Biliopancreatic Surgery Unit, Hospital Universitario Ramón y Cajal, 10Department of Pathology, Hospital Universitario Ramón y Cajal, 11Department of Radiation Oncology, Hospital Universitario Ramón y Cajal, 12Department of Cancer, Instituto de Investigaciones Biomédicas “Alberto Sols” (IIBM), 13Cancer Stem Cell and Fibroinflammatory Group, Chronic Diseases and Cancer, Area 3, IRYCIS JoVE 65229 Cancer Research
下流循環フリーDNAアプリケーションのための標準化されたリキッドバイオプシー前分析プロトコル Julie Earl1, Silvia Calabuig-Fariñas1, María Eugenia Sarasquete1, Laura Muinelo Romay1, Sara Lopez-Tarruella1, Beatriz Bellosillo Paricio1, Marta Rodríguez1, Karmele Valencia Leoz1, Marta Dueñas Porto1, Noelia Tarazona1, Javier Hernandez Losa1, Rodrigo Almeida Toledo1 1The Liquid Biopsy and Biomarker Working Module, the Biomedical Research Network in Cancer (CIBERONC) JoVE 64123 Cancer Research